Journal Report

Targeted Oncology

Download PDF
Journal Information
Journal Title
Targeted Oncology
Publisher
Adis
ISSN
1776-2596
E-ISSN
1776-260X
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Circulating Tumour DNA (ctDNA) as an Emerging Biomarker of Response in Early-Phase Oncology Drug Development: A Systematic Review
Nadav Harel, Anthony Hamilton, Thomas C. T. Cope et al.
2026-11-10
DOI: 10.1007/s11523-026-01269-2
Clinical Significance of Comprehensive Genomic Profiling According to RAS and BRAF Status in Metastatic Colorectal Cancer
Kazuki Ogawa, Hiroyuki Arai, Yuka Makino et al.
2026-11-10
DOI: 10.1007/s11523-026-01272-7
Imlunestrant as Monotherapy or in Combination with Abemaciclib in ER+, HER2− Advanced Breast Cancer: Chinese Subgroup Analysis of the Phase III Randomized EMBER-3 Study
Xiaojia Wang, Jingwei Xu, Zhongsheng Tong et al.
2026-11-9
DOI: 10.1007/s11523-026-01267-4
Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study
Pier Luigi Zinzani, David Šálek, Christopher R. Flowers et al.
2026-11-3
DOI: 10.1007/s11523-026-01268-3
Understanding the Patient Journey in Extrapulmonary Neuroendocrine Carcinoma: A Podcast Manuscript
Aman Chauhan, Deborah Robertson, Susan Meckler-Plummer
2026-11-2
DOI: 10.1007/s11523-026-01262-9
Real-World Safety and Effectiveness of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer: Final Analysis of the RAPIT Study
Chao-Yuan Huang, Chi-Ping Huang, Yu-Yi Huang et al.
2026-10-25
DOI: 10.1007/s11523-026-01254-9
Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study
Zeynep Sıla Gökdere, Taha Koray Şahin, İrem Bilgetekin et al.
2026-10-22
DOI: 10.1007/s11523-026-01261-w
Treatment Trends and Survival Outcomes in Clinical Stage III Melanoma: Real-World Analysis of NCDB Data
Daniel Park, Helena T. Wu, Dani R. Castillo et al.
2026-10-22
DOI: 10.1007/s11523-026-01265-6
Efficacy and Safety of Infliximab for Management of Immune-Related Adverse Events: A Retrospective Analysis
Filippos Koutroumpakis, Yifan Xu, Kevin Shi et al.
2026-10-21
DOI: 10.1007/s11523-026-01264-7
Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
Jacob Sands, Shun Lu, Joachim G. Aerts et al.
2026-10-20
DOI: 10.1007/s11523-026-01237-w
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 09:59